Grants & Programs

Conquering cancer — through expanded research, applied knowledge, coordinated partnerships, and community commitment — is the focus of everything we do at the Cancer Research Institute.

CRI’s programs span laboratory research and training, translational investigation, preclinical discovery, a comprehensive clinical investigation and immunotherapy development strategy, and data-sharing through open access publishing. All of these complementary efforts are necessary for CRI to reach its ultimate goal of bringing more FDA-approved immunotherapies to patients with all types of cancer.

Apply for Funding

Interested in applying for a grant or fellowship?

Learn More

  • Clinical Accelerator

    A powerful program that faciliates collaboration among nonprofits, academic clinicians, and biopharmaceutical companies to speed up refinement of cancer immunotherapies.

    Learn More

  • Grants & Fellowships

     Grants and Fellowships

    We offer support for scientists at any stage of their career and at all levels of scientific inquiry, from basic research to coordinated clinical trials.

    Learn More

  • Cancer Immunotherapy Consortium

     Cancer Immunotherapy Consortium

    International association of biotech and pharma companies and academic organizations engaged in late-stage cancer immunotherapy development.

    Learn More

  • Conferences & Meetings

     Conferences & Meetings

    As a well-known and respected organization among basic and tumor immunologists, CRI has the ability to convene the world's top scientists to discuss breaking developments or significant challenges in the field at our annual symposia series and colloquia.

    Learn More

  • Cancer Immunity

    The official open access, peer-reviewed academic journal of Cancer Research Institute, dedicated to publishing laboratory and clinical research papers on the immune response to cancer.

    Learn More